ArticleJournal of translational medicine2023

A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma.

Simon Garinet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.